About
Nanocan Therapeutics Corporation develops a nanotechnology-based drug delivery platform using patented nanoparticle materials to enable sustained local delivery of cancer therapies that induce systemic anti-cancer (abscopal) effects.
Explore Nanocan Therapeutics Corporation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.